Luigi Mangione is scheduled to go before a New York state jury on June 8 over the killing of a prominent health insurance executive, even as a separate federal case continues to loom later in the year.
A judge at Manhattan’s top trial court locked in the early-summer date on Friday. As Mangione was escorted out in restraints, he voiced sharp opposition, arguing that facing two cases over the same killing amounts to being tried twice for a single act. In plain terms, he said, one case plus another still equals one alleged crime.
The pushback echoed concerns raised by his defense team, which warned the schedule leaves little time to prepare and accused the state of racing ahead simply to beat the federal case to the courtroom.
Mangione has entered not-guilty pleas across the board. In the state case, that includes accusations tied to murder, weapons and forged documents. He has also denied stalking allegations brought separately at the federal level.
The judge overseeing the state matter made clear he was irritated by what he described as shifting positions by federal authorities, who had earlier suggested the state case would take priority. City officials, for their part, have argued they should proceed first because Mangione was initially taken into custody under state authority.
The case centers on the December 4, 2024 killing of Brian Thompson, the head of UnitedHealth Group’s health insurance arm. Thompson was shot outside a Midtown Manhattan hotel where he had been staying for an investor gathering. The attack drew swift condemnation from public leaders, while also igniting a wave of public anger toward the U.S. health insurance system and its costs.
After a five-day manhunt, Mangione, now 27, was arrested in Pennsylvania and has remained behind bars since. Online, he has attracted an unusual following among critics of the insurance industry, some of whom portray him as a symbol of frustration with denied claims and rising medical bills.
An earlier attempt to frame the state case as terrorism was dismissed after the court found insufficient grounds to say the alleged act was meant to influence public policy.
On the federal track, the most serious accusations were trimmed away on technical grounds earlier this year, taking capital punishment off the table. Even so, a conviction on the remaining charge could still carry a life sentence.
For now, June 8 stands as the next major flashpoint, setting the stage for a trial that will unfold amid lingering debate over whether one man should face two courtrooms for one deadly act.
